Table Info

Table 2.

Peptides derived from RWQWRWQWR (¹R⁵R⁹R) sequence containing RGD or DGR motifs. Characterization by RP-HPLC and ESI-QTOF MS, and cytotoxic effect against breast cancer cells and non-cancerous fibroblast primary cell culture

Code	Sequence	RP-HPLC		ESI-MS (M)		IC₅₀, µg/mL (µM)
Code	Sequence	t_R (min)	Purity (%)	a	b	MCF-7	Fibroblasts
¹R⁵R⁹R	RWQWRWQWR	6.3	92	1,485.75	1,485.88	120 (81)	> 200 (135)*
14	RGD-X-RWQWRWQWR	6.3	92	1,928.21	1,928.48	27 (14)	108 (56)
15	RWQWRWQWR-Ahx-RGD	6.3	96	1,928.21	1,928.46	> 200 (104)*	> 200 (104)*
16	RGD-X-RWQWRWQWR-X-RGD	6.1	84	2,369.69	2,368.99	> 200 (84)*	> 200 (84)*
17	DGR-X-RWQWRWQWR-X-RGD	6.0	99	2,369.69	2,369.67	> 200 (84)*	> 200 (84)*
18	DGR-X-RWQWRWQWR-X-DGR	6.1	95	2,369.69	2,369.80	> 200 (84)*	> 200 (84)*
R¹R⁵R⁹R	RRWQWRWQWR	6.2	93	1,631.87	1,641.88	112 (68)	> 200 (121)*
19	RGD-X-RRWQWRWQWR	6.2	95	2,084.39	2,084.62	82 (39)	195 (94)
20	RRWQWRWQWR-Ahx-RGD	6.2	98	2,084.39	2,084.62	> 200 (96)*	> 200 (96)*
21	RGD-X-RRWQWRWQWR-X-RGD	6.6	97	2,525.88	2,525.42	> 200 (79)*	> 200 (79)*
22	DGR-X-RRWQWRWQWR-X-RGD	6.2	95	2,525.88	2,525.95	> 200 (79)*	> 200 (79)*
23	DGR-X-RRWQWRWQWR-X-DGR	6.2	98	2,525.88	2,426.321	> 200 (79)*	> 200 (79)*

*: IC₅₀ could not be reached at the evaluated concentrations; a: theoretical; b: experimental monoisotopic mass in uma; ESI-MS: electrospray ionization mass spectrometry; IC₅₀: half maximal inhibitory concentration; RP-HPLC: reversed-phase high-performance liquid chromatography; t_R: retention time

Supplementary materials

The supplementary figures for this article are available at: https://www.explorationpub.com/uploads/Article/file/100852_sup_1.pdf.

Declarations

Author contributions

ABC: Conceptualization, Software, Validation, Formal analysis, Investigation, Data curation, Writing—original draft. DCA: Validation, Formal analysis, Investigation, Data curation. YVC: Validation, Formal analysis, Investigation. CPG: Conceptualization, Project administration, Funding acquisition, Resources. AUP and JLM: Conceptualization, Methodology, Data curation, Supervision, Resources. ZRM: Conceptualization, Resources, Supervision, Writing—review & editing, Project administration, Funding acquisition, Resources. JGC: Conceptualization, Resources, Supervision, Writing—original draft, Writing—review & editing, Project administration, Funding acquisition, Resources. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All the experiments were carried out in compliance with the guidelines and standards of Resolution 08430 of 1993 of the Colombian Ministry of Health and Law 84 of 27 December 1989 and were governed by the principles and standards for the care and use of animals, decreed by the institutional Ethics Committee from Science Faculty (Act 03-2018) of the National University of Colombia.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.

Funding

This research was funded by COLCIENCIAS grant number [RC No. 706-2018]. Project: “Desarrollo de un medicamento contra el cáncer de mama basado en un péptido polivalente derivado de la LfcinB: Estudio de la fase preclínica (fase cero), caracterización fisicoquímica de un lote del fármaco para estudios preclínicos”. Code [110180762973]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

References

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778–89. [DOI]

Testa U, Castelli G, Pelosi E. Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments. Med Sci (Basel). 2020;8:18. [DOI] [PubMed] [PMC]

Onkar SS, Carleton NM, Lucas PC, Bruno TC, Lee AV, Vignali DAA, et al. The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes. Cancer Discov. 2023;13:23–40. [DOI] [PubMed] [PMC]

Johnson KS, Conant EF, Soo MS. Molecular Subtypes of Breast Cancer: A Review for Breast Radiologists. J Breast Imaging. 2021;3:12–24. [DOI] [PubMed]

Burguin A, Diorio C, Durocher F. Breast Cancer Treatments: Updates and New Challenges. J Pers Med. 2021;11:808. [DOI] [PubMed] [PMC]

Kc M, Fan J, Hyslop T, Hassan S, Cecchini M, Wang S, et al. Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US. JAMA Netw Open. 2023;6:e2323115. [DOI] [PubMed] [PMC]

Xie M, Liu D, Yang Y. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol. 2020;10:200004. [DOI] [PubMed] [PMC]

Kordi M, Borzouyi Z, Chitsaz S, Asmaei MH, Salami R, Tabarzad M. Antimicrobial peptides with anticancer activity: Today status, trends and their computational design. Arch Biochem Biophys. 2023;733:109484. [DOI] [PubMed]

Zhang Y, Lima CF, Rodrigues LR. Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy. Nutr Rev. 2014;72:763–73. [DOI] [PubMed]

10.

Richardson A, de Antueno R, Duncan R, Hoskin DW. Intracellular delivery of bovine lactoferricin’s antimicrobial core (RRWQWR) kills T-leukemia cells. Biochem Biophys Res Commun. 2009;388:736–41. [DOI] [PubMed]

11.

Barragán-Cárdenas AC, Insuasty-Cepeda DS, Vargas-Casanova Y, López-Meza JE, Parra-Giraldo CM, Fierro-Medina R, et al. Changes in Length and Positive Charge of Palindromic Sequence RWQWRWQWR Enhance Cytotoxic Activity against Breast Cancer Cell Lines. ACS Omega. 2023;8:2712–22. [DOI] [PubMed] [PMC]

12.

Li L, Chen X, Yu J, Yuan S. Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors. Front Oncol. 2022;12:837952. [DOI] [PubMed] [PMC]

13.

Insuasty-Cepeda DS, Barragán-Cárdenas AC, Ochoa-Zarzosa A, López-Meza JE, Fierro-Medina R, García-Castañeda JE, et al. Peptides Derived from (RRWQWRMKKLG)₂-K-Ahx Induce Selective Cellular Death in Breast Cancer Cell Lines through Apoptotic Pathway. Int J Mol Sci. 2020;21:4550. [DOI] [PubMed] [PMC]

14.

Lara-Márquez M, Báez-Magaña M, Raymundo-Ramos C, Spagnuolo PA, Macías-Rodríguez L, Salgado-Garciglia R, et al. Lipid-rich extract from Mexican avocado (Persea americana var. drymifolia) induces apoptosis and modulates the inflammatory response in Caco-2 human colon cancer cells. J Funct Foods. 2020;64:103658. [DOI]

15.

Luminex LTG [Internet]. Diasorin; [cited 2019 Oct 29]. Available from: https://us.diasorin.com/en/luminex-ltg

16.

LEGENDplex^TM Human Macrophage/Microglia Panel [Internet]. BioLegend; [cited 2023 Dec 1]. Available from: https://www.biolegend.com/Files/Images/media_assets/pro_detail/datasheets/75062_Hu_Macrophage-Microglia_Panel_V01.pdf

17.

Sandoval-Usme MC, Umaña-Pérez A, Guerra B, Hernández-Perera O, García-Castellano JM, Fernández-Pérez L, et al. Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells. PLoS One. 2014;9:e87769. [DOI] [PubMed] [PMC]

18.

Cabezas-Perez RJ, Vallejo-Pulido AF, Freyre-Bernal SI, Umana-Perez A, Sanchez-Gomez M. IGF-II y la gonadotropina corionica regulan la proliferacion, migracion e invasion de celulas de trofoblasto humano. Acta Biol Colomb. 2011;16:143–52. Spanish.

19.

ITGAV [Internet]. The Human Protein Atlas; [cited 2023 Dec 2]. Available from: https://www.proteinatlas.org/ENSG00000138448-ITGAV/cell+line

20.

Gai Y, Jiang Y, Long Y, Sun L, Liu Q, Qin C, et al. Evaluation of an Integrin α_vβ₃ and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging. Mol Pharm. 2020;17:349–58. [DOI] [PubMed] [PMC]

21.

Mader JS, Salsman J, Conrad DM, Hoskin DW. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther. 2005;4:612–24. [DOI] [PubMed]

22.

Mader JS, Richardson A, Salsman J, Top D, de Antueno R, Duncan R, et al. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. Exp Cell Res. 2007;313:2634–50. [DOI] [PubMed]

23.

Fester N, Zielonka E, Goldmann J, Frombach A, Müller-Kuller U, Gutfreund N, et al. Enhanced pro-apoptosis gene signature following the activation of TAp63α in oocytes upon γ irradiation. Cell Death Dis. 2022;13:204. [DOI] [PubMed] [PMC]

24.

Thomadaki H, Talieri M, Scorilas A. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biol Chem. 2006;387:1081–6. [DOI] [PubMed]

25.

Insuasty-Cepeda DS, Barragán-Cárdenas AC, Ardila-Chantre N, Cárdenas-Martínez KJ, Rincón-Quiñones I, Vargas-Casanova Y, et al. Non-natural amino acids into LfcinB-derived peptides: effect in their (i) proteolytic degradation and (ii) cytotoxic activity against cancer cells. R Soc Open Sci. 2023;10:221493. [DOI] [PubMed] [PMC]

26.

Rahman R, Fonseka AD, Sua S, Ahmad M, Rajendran R, Ambu S, et al. Inhibition of breast cancer xenografts in a mouse model and the induction of apoptosis in multiple breast cancer cell lines by lactoferricin B peptide. J Cell Mol Med. 2021;25:7181–9. [DOI] [PubMed] [PMC]

27.

El-Fakharany EM, Ashry M, Abd-Elaleem AH, Romeih MH, Morsy FA, Shaban RA, et al. Therapeutic efficacy of Nano-formulation of lactoperoxidase and lactoferrin via promoting immunomodulatory and apoptotic effects. Int J Biol Macromol. 2022;220:43–55. [DOI] [PubMed]

28.

Cutone A, Rosa L, Ianiro G, Lepanto MS, Bonaccorsi di Patti MC, Valenti P, et al. Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action. Biomolecules. 2020;10:456. [DOI] [PubMed] [PMC]

29.

Pan W, Chen P, Chen YS, Hsu H, Lin C, Chen W. Bovine lactoferricin B induces apoptosis of human gastric cancer cell line AGS by inhibition of autophagy at a late stage. J Dairy Sci. 2013;96:7511–20. [DOI] [PubMed]

30.

Furlong SJ, Mader JS, Hoskin DW. Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts. Exp Mol Pathol. 2010;88:371–5. [DOI] [PubMed]